# Immunovant, Inc.: Form 4, filed Dec 20, 2019

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 4
- Filed: 2019-12-20
- Accepted by EDGAR: Dec 20, 2019, 17:28 ET
- Period: 2019-12-18
- Accession: 0001104659-19-075134
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000110465919075134/xslF345X03/a4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000110465919075134/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000110465919075134/xslF345X03/a4.xml

Filed Dec 20, 2019.
Source: SEC EDGAR, the filing index for accession 0001104659-19-075134. Last ingested by Listed: Oct 30, 2026, 16:48 ET. No prices; not investment advice.